SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-060617
Filing Date
2018-10-05
Accepted
2018-10-05 06:01:11
Documents
7
Period of Report
2018-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-36351_18k.htm 8-K 29572
2 EX-1.1 a18-36351_1ex1d1.htm EX-1.1 294263
3 EX-5.1 a18-36351_1ex5d1.htm EX-5.1 15908
4 EX-99.1 a18-36351_1ex99d1.htm EX-99.1 10511
5 GRAPHIC g363511kii001.gif GRAPHIC 1788
6 GRAPHIC g363511kii002.gif GRAPHIC 4417
7 GRAPHIC g363511kii003.gif GRAPHIC 1044
  Complete submission text file 0001104659-18-060617.txt   361845
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 181109129
SIC: 2834 Pharmaceutical Preparations